# Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease

> **NCT07739368** · PHASE3 · COMPLETED · sponsor: **Jiangsu Aosaikang Pharmaceutical Co., Ltd.** · enrollment: 122 (actual)

## Conditions studied

- Iron Deficiency Anaemia

## Interventions

- **DRUG:** Ferric Maltol
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT07739368
- **Lead sponsor:** Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2025-02-20
- **Final completion:** 2025-03-20
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07739368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07739368, "Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07739368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*